Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
Patricio Molero, Josep Antoni Ramos‐Quiroga, Rocio Martín‐Santos, et al.
CNS Drugs (2018) Vol. 32, Iss. 5, pp. 411-420
Closed Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases
Tadahiro Numakawa, Haruki Odaka, Naoki Adachi
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3650-3650
Open Access | Times Cited: 282
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 166
Monoaminergic system and depression
Laura Pérez-Caballero, Sonia Torres-Sánchez, Cristina Romero-López-Alberca, et al.
Cell and Tissue Research (2019) Vol. 377, Iss. 1, pp. 107-113
Closed Access | Times Cited: 161
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 59
Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery
Lili Xu, Chun Wang, Chun-Mei Deng, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e239321-e239321
Open Access | Times Cited: 45
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial
Shuo Wang, Chun-Mei Deng, Yuan Zeng, et al.
BMJ (2024), pp. e078218-e078218
Open Access | Times Cited: 26
Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis
Shuying Li, Wenqin Zhou, Ping Li, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 720-728
Open Access | Times Cited: 23
Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery
Yu Chen, Yu Guo, Han Wu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 3, pp. e240953-e240953
Open Access | Times Cited: 20
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 147
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Cheng‐Ta Li, Kai‐Chun Yang, Wei‐Chen Lin
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 142
Esketamine for treatment resistant depression
Jennifer Swainson, Rejish K. Thomas, Shaina Archer, et al.
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 10, pp. 899-911
Closed Access | Times Cited: 113
HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs
Fangchao Yin, Xu Zhang, Li Wang, et al.
Lab on a Chip (2020) Vol. 21, Iss. 3, pp. 571-581
Closed Access | Times Cited: 96
Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
Zsolt Gáll, Szidónia Farkas, Ákos Albert, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 801-801
Open Access | Times Cited: 82
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
American Journal of Psychiatry (2021) Vol. 179, Iss. 2, pp. 122-131
Closed Access | Times Cited: 72
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 71
Effects of esketamine on analgesia and postpartum depression after cesarean section: A randomized, double-blinded controlled trial
Wei Wang, Hua Xu, Bin Ling, et al.
Medicine (2022) Vol. 101, Iss. 47, pp. e32010-e32010
Open Access | Times Cited: 49
Global Trends and Hotspots in Esketamine Research: A Bibliometric Analysis of Past and Estimation of Future Trends
Xiang Li, Ping Xiang, Jianfen Liang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1131-1142
Open Access | Times Cited: 40
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Gustavo C. Medeiros, Todd D. Gould, William L. Prueitt, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3658-3669
Open Access | Times Cited: 40
Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: A randomized, double-blinded controlled trial
Wei Wang, Bin Ling, Qian Chen, et al.
Medicine (2023) Vol. 102, Iss. 9, pp. e33086-e33086
Open Access | Times Cited: 34
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Efficacy and safety of perioperative application of ketamine on postoperative depression: A meta-analysis of randomized controlled studies
Jie Guo, Di Qiu, Hanwen Gu, et al.
Molecular Psychiatry (2023)
Open Access | Times Cited: 27
Mini-dose esketamine–dexmedetomidine combination to supplement analgesia for patients after scoliosis correction surgery: a double-blind randomised trial
Ying Zhang, Fan Cui, Jiahui Ma, et al.
British Journal of Anaesthesia (2023) Vol. 131, Iss. 2, pp. 385-396
Open Access | Times Cited: 24
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Maurizio Fava, Stephen M. Stahl, Sara De Martin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1463-1476
Open Access | Times Cited: 23
Positive affect and reward processing in the treatment of depression, anxiety and trauma
Michelle G. Craske, Barnaby D. Dunn, Alicia E. Meuret, et al.
Nature Reviews Psychology (2024)
Closed Access | Times Cited: 15
Effect of Esketamine on Postoperative Delirium in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass: A Randomized Controlled Trial
Xinglong Xiong, Yi Shao, Dongxu Chen, et al.
Anesthesia & Analgesia (2024) Vol. 139, Iss. 4, pp. 743-753
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top